Nanobiotix S.A. (NASDAQ:NBTX – Get Free Report)’s stock price dropped 1% during trading on Friday . The company traded as low as $2.82 and last traded at $2.83. Approximately 44,226 shares traded hands during mid-day trading, an increase of 18% from the average daily volume of 37,454 shares. The stock had previously closed at $2.86.
Nanobiotix Stock Down 1.0 %
The firm has a 50 day moving average price of $3.38 and a two-hundred day moving average price of $4.52.
Nanobiotix Company Profile
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Featured Stories
- Five stocks we like better than Nanobiotix
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- CD Calculator: Certificate of Deposit Calculator
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- P/E Ratio Calculation: How to Assess Stocks
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
